Molecules (May 2022)

Systematically Exploring the Chemical Ingredients and Absorbed Constituents of <i>Polygonum capitatum</i> in Hyperuricemia Rat Plasma Using UHPLC-Q-Orbitrap HRMS

  • Huanyu Guan,
  • Pengfei Li,
  • Qian Wang,
  • Fanli Zeng,
  • Daoping Wang,
  • Mei Zhou,
  • Meng Zhou,
  • Xun He,
  • Shanggao Liao,
  • Weidong Pan

DOI
https://doi.org/10.3390/molecules27113521
Journal volume & issue
Vol. 27, no. 11
p. 3521

Abstract

Read online

Polygonum capitatum as an ethnic medicine has been used to treat urinary tract infections, pyelonephritis and urinary calculi. In our previous study, P. capitatum was found to have anti-hyperuricemia effects. Nevertheless, the active constituents of P. capitatum for treating hyperuricemia were still unclear. In this study, an ultra-high-performance liquid chromatography coupled to quadrupole/orbitrap high-resolution mass spectrometry (UHPLC-Q-Orbitrap HRMS) was used to comprehensively detect the chemical ingredients of P. capitatum and its absorbed constituents in the plasma of hyperuricemia rats for the first time. Xcalibur 3.0 and Compound Discoverer 2.0 software coupled to mzCloud and ChemSpider databases were utilized for qualitative analysis. A total of 114 chemical components including phenolics, flavonoids, tannins, phenylpropanoids, amino acids, amides and others were identified or tentatively characterized based on the exact mass, retention time and structural information. Compared to the previous P. capitatum study, an additional 66 different components were detected. Moreover, 68 related xenobiotics including 16 prototype components and 52 metabolites were found in the plasma of hyperuricemia rats. The metabolic pathways included ring fission, hydrolysis, decarboxylation, dehydroxylation, methylation, glucuronidation and sulfation. This work may provide important information for further investigation on the active constituents of P. capitatum and their action mechanisms for anti-hyperuricemia effects.

Keywords